Fisher Wallace Laboratories today announced the results of a brain stimulation study involving the Fisher Wallace Cranial Stimulator, a portable medical device that treats depression, anxiety and insomnia. The study, published in The Neuroscientist and authored by Dr. Felipe Fregni, assistant professor in neurology at Harvard Medical School, analyzes a decade's worth of research on the brain stimulation technology used by the Fisher Wallace Cranial Stimulator.
Included in the analysis is a 2006 study by Fregni in which patients who received non-invasive brain stimulation scored lower on tests for depression versus patients who were treated with a placebo device.
Fregni states, "The Fisher Wallace Cranial Stimulator decreases the level of neuronal activity in the motor cortex, a strong indication of why the device may be effective in some conditions with high cortical activity levels such as anxiety."
Charles Avery Fisher, president of Fisher Wallace Laboratories, states, "Top psychiatrists such as Dr. Richard Brown and Dr. Andres San Martin at Columbia University have reported an 80 percent success rate using the device to treat depression, anxiety and insomnia in over 270 patients. Dr. Fregni's paper now adds to the body of science that supports these extraordinary results."
SOURCE Fisher Wallace Laboratories